Abstract Submission Guidelines

Submit Abstracts


Instructions for Submission of Abstracts

Online Abstracts Submission are available for following categories. Please click the category for detailed information.

Abstract Submission deadline is June 1st, 2012.

Abstracts evaluation

Notification about abstract acceptance will be send by June 15th, 2012 (preliminary date).

Instructions for Preparation of Abstracts

Two reviewers appointed by the Conference Scientific Committee (CSC) for each topic will assess all submissions. All abstracts are assessed on the following criteria:
  • The abstract content is presented in the appropriate mode (see presentation modes below).
  • Submissions of primary and secondary empirical research include analyses and a summary of findings. It is not sufficient to state “the data will be analysed”
  • The abstract content is explicitly linked to an aspect of paediatric drug development. 
  • The submission has not been presented at a previous EuPFI conference and has obtained appropriate ethical approval.
  • Spelling, grammar and English are satisfactory, and the abstract does not exceed the word limit (250 words).
  • The CSC has the final decision on the inclusion of abstracts.
  • The maximum number for presentations for presenting authors is one oral presentation and two poster presentations. There is no limit on the number of presentations as a non-presenting co-author.
Note: All accepted abstracts will be published on the EuPFI website . It is assumed Authors give consent and authorise the CSC to publish their abstract.

Presentation should be submitted in one of the following formats:

A. Oral or Poster presentation

Please use the Online Abstract Submission form. For details please see the Online Abstract Submission System.

Oral presentations are usually allocated a 12 minute slot divided as follows: 10 minutes talk, 2 minutes discussion.
Abstracts should include

  • Title
    Provide a title of 15 words or less
  • Author(s) details
    (name and affiliation). Name: first name(s) followed by surname(s); Institution of Affiliation. Authors should be no more than 10.
  • The body of the text should be no longer than 250 words and include:
    • Background: state the primary objectives of the study, including the main research questions, aims or theory being tested.
    • Methods: quantitative studies should include design, participants (including number of participants), measures; qualitative studies should include design, participants, methods of data collection and analysis.
    • Findings: quantitative studies should include a summary of the results; qualitative studies should include a description of the main findings such as the themes or categories generated. Note: it is not acceptable to state "results will be discussed".
    • Discussion: some discussion of the possible contribution to, or implications for, paedistric drug development
    • Please do include a list of references at the end of your abstract.

In the case of further questions please do not hesitate to contact us at abstracts@eupfi2012prague.com.


General information

Thank you for your interest in submitting an abstract for EuPFI 2012 in Prague!

Conference Secretariat:  Kurfürstenstraße 59 55118 Mainz/Germany | Phone: +49 6131 9769-0 | Fax: +49 6131 9769-69 | e-mail: apv@apv-mainz.de |    Website: www.apv-mainz.de
Home | Sitemap | apv@apv-mainz.de

Original Text: